Literature DB >> 26865629

Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.

Yuan Liao1, Bin Lu1, Qiang Ma1, Gang Wu2, Xiangru Lai1, Jiashu Zang1, Ying Shi1, Dongxiang Liu3, Feng Han4, Naiming Zhou5.   

Abstract

Human neuropeptide S (NPS) and its cognate receptor regulate important biological functions in the brain and have emerged as a future therapeutic target for treatment of a variety of neurological and psychiatric diseases. The human NPS (hNPS) receptor has been shown to dually couple to Gαs- and Gαq-dependent signaling pathways. The human NPS analog hNPS-(1-10), lacking 10 residues from the C terminus, has been shown to stimulate Ca(2+)mobilization in a manner comparable with full-length hNPSin vitrobut seems to fail to induce biological activityin vivo Here, results derived from a number of cell-based functional assays, including intracellular cAMP-response element (CRE)-driven luciferase activity, Ca(2+)mobilization, and ERK1/2 phosphorylation, show that hNPS-(1-10) preferentially activates Gαq-dependent Ca(2+)mobilization while exhibiting less activity in triggering Gαs-dependent CRE-driven luciferase activity. We further demonstrate that both Gαq- and Gαs-coupled signaling pathways contribute to full-length hNPS-mediated activation of ERK1/2, whereas hNPS-(1-10)-promoted ERK1/2 activation is completely inhibited by the Gαqinhibitor UBO-QIC but not by the PKA inhibitor H89. Moreover, the results of Ala-scanning mutagenesis of hNPS-(1-13) indicated that residues Lys(11)and Lys(12)are structurally crucial for the hNPS receptor to couple to Gαs-dependent signaling. In conclusion, our findings demonstrate that hNPS-(1-10) is a biased agonist favoring Gαq-dependent signaling. It may represent a valuable chemical probe for further investigation of the therapeutic potential of human NPS receptor-directed signalingin vivo.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein; G protein-coupled receptor (GPCR); extracellular-signal-regulated kinase (ERK); neuropeptide; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 26865629      PMCID: PMC4817180          DOI: 10.1074/jbc.M115.704122

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  MAP kinases.

Authors:  Z Chen; T B Gibson; F Robinson; L Silvestro; G Pearson; B Xu; A Wright; C Vanderbilt; M H Cobb
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

2.  Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I.

Authors:  Virginie Bernier; Rino Stocco; Michael J Bogusky; Joseph G Joyce; Christine Parachoniak; Karl Grenier; Michael Arget; Marie-Claude Mathieu; Gary P O'Neill; Deborah Slipetz; Michael A Crackower; Christopher M Tan; Alex G Therien
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

3.  Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.

Authors:  Adelheid L Roth; Erika Marzola; Anna Rizzi; Marika Arduin; Claudio Trapella; Corrado Corti; Raffaella Vergura; Prisca Martinelli; Severo Salvadori; Domenico Regoli; Mauro Corsi; Paolo Cavanni; Girolamo Caló; Remo Guerrini
Journal:  J Biol Chem       Date:  2006-05-23       Impact factor: 5.157

4.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

5.  Pharmacological characterization of human and murine neuropeptide s receptor variants.

Authors:  Rainer K Reinscheid; Yan-Ling Xu; Naoe Okamura; Joanne Zeng; Shinjae Chung; Rama Pai; Zhiwei Wang; Olivier Civelli
Journal:  J Pharmacol Exp Ther       Date:  2005-09-06       Impact factor: 4.030

Review 6.  Functional selectivity in adrenergic and angiotensin signaling systems.

Authors:  Chetan B Patel; Nabila Noor; Howard A Rockman
Journal:  Mol Pharmacol       Date:  2010-09-20       Impact factor: 4.436

7.  Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats.

Authors:  Bernard Beck; Brigitte Fernette; Alain Stricker-Krongrad
Journal:  Biochem Biophys Res Commun       Date:  2005-07-08       Impact factor: 3.575

8.  Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.

Authors:  Yan-Ling Xu; Rainer K Reinscheid; Salvador Huitron-Resendiz; Stewart D Clark; Zhiwei Wang; Steven H Lin; Fernando A Brucher; Joanne Zeng; Nga K Ly; Steven J Henriksen; Luis de Lecea; Olivier Civelli
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

9.  Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.

Authors:  Diane Gesty-Palmer; Minyong Chen; Eric Reiter; Seungkirl Ahn; Christopher D Nelson; Shuntai Wang; Allen E Eckhardt; Conrad L Cowan; Robert F Spurney; Louis M Luttrell; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

10.  Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake.

Authors:  Kirsty L Smith; Michael Patterson; Waljit S Dhillo; Sejal R Patel; Nina M Semjonous; James V Gardiner; Mohammad A Ghatei; Stephen R Bloom
Journal:  Endocrinology       Date:  2006-03-30       Impact factor: 4.736

View more
  14 in total

1.  Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.

Authors:  Stewart D Clark; Terrence P Kenakin; Steven Gertz; Carla Hassler; Elaine A Gay; Tiffany L Langston; Rainer K Reinscheid; Scott P Runyon
Journal:  Neuropharmacology       Date:  2017-03-03       Impact factor: 5.250

2.  Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala.

Authors:  Thomas Grund; Inga D Neumann
Journal:  Neuropsychopharmacology       Date:  2017-08-14       Impact factor: 7.853

Review 3.  State-of-the-art: functional fluorescent probes for bioimaging and pharmacological research.

Authors:  Lu Lu; Zhou-Yue Wu; Xin Li; Feng Han
Journal:  Acta Pharmacol Sin       Date:  2018-11-28       Impact factor: 6.150

Review 4.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

Review 5.  Heterotrimeric Gq proteins as therapeutic targets?

Authors:  Evi Kostenis; Eva Marie Pfeil; Suvi Annala
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

6.  Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis.

Authors:  Thomas Grund; Stephanie Goyon; Yuting Li; Marina Eliava; Haikun Liu; Alexandre Charlet; Valery Grinevich; Inga D Neumann
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

7.  Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation?

Authors:  Jonathan G Schlegel; Mariam Tahoun; Alexander Seidinger; Jan H Voss; Markus Kuschak; Stefan Kehraus; Marion Schneider; Michaela Matthey; Bernd K Fleischmann; Gabriele M König; Daniela Wenzel; Christa E Müller
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-19

8.  Neuropeptide S (NPS) variants modify the signaling and risk effects of NPS Receptor 1 (NPSR1) variants in asthma.

Authors:  Nathalie Acevedo; Sini Ezer; Simon Kebede Merid; Vincent D Gaertner; Cilla Söderhäll; Mauro D'Amato; Michael Kabesch; Erik Melén; Juha Kere; Ville Pulkkinen
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

9.  Neuropeptide S Receptor Stimulation Excites Principal Neurons in Murine Basolateral Amygdala through a Calcium-Dependent Decrease in Membrane Potassium Conductance.

Authors:  Sion Park; Pia Flüthmann; Carla Wolany; Lena Goedecke; Hannah Maleen Spenner; Thomas Budde; Hans-Christian Pape; Kay Jüngling
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

10.  Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation.

Authors:  Shishi Li; Huaye Pan; Chao Tan; Yaping Sun; Yanrui Song; Xuan Zhang; Wei Yang; Xuexiang Wang; Dan Li; Yu Dai; Qiang Ma; Chenming Xu; Xufen Zhu; Lijun Kang; Yong Fu; Xuejun Xu; Jing Shu; Naiming Zhou; Feng Han; Dajiang Qin; Wendong Huang; Zhong Liu; Qingfeng Yan
Journal:  Stem Cell Reports       Date:  2018-02-15       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.